Pfizer director granted phantom stock units

Quincey James reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Quincey James reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director James Quincey received a grant of phantom stock units as deferred board compensation. On March 27, 2026, he was awarded 1,433.062 Phantom Stock Units, each linked to one share of Pfizer common stock and valued at $27.04 per unit. Following this award, his reported balance rose to 77,317.538 phantom units. These units represent deferred director compensation, including dividend equivalents, and will be settled in cash or common stock at his election after he retires from the Board.

Insider Trade Summary

Grant/Award: 1,433.062 shares

Grant/Award 1 txn

Insider Quincey James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	1,433.062	$27.04	$39K

Holdings After Transaction: Phantom Stock Units — 77,317.538 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom units granted: 1,433.062 units Grant reference price: $27.04 per unit Total phantom units after grant: 77,317.538 units +1 more

4 metrics

Phantom units granted 1,433.062 units Phantom Stock Units award on March 27, 2026

Grant reference price $27.04 per unit Valuation per Phantom Stock Unit for the award

Total phantom units after grant 77,317.538 units James Quincey’s phantom balance following the transaction

Underlying common stock link 1 unit : 1 share Each phantom unit represents one share of common stock

Key Terms

Phantom Stock Units, deferred director's compensation, dividend equivalents, settled in cash or common stock

4 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

deferred director's compensation financial

"These units represent deferred director's compensation (including dividend equivalents thereon)"

dividend equivalents financial

"deferred director's compensation (including dividend equivalents thereon)"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

settled in cash or common stock financial

"that are settled in cash or common stock at the director's election"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pfizer (PFE) director James Quincey report in this Form 4?

James Quincey reported receiving a grant of 1,433.062 Phantom Stock Units as deferred director compensation. Each unit tracks one Pfizer common share and increases his total phantom unit balance to 77,317.538, with settlement after he retires from the Board.

Are James Quincey’s Pfizer (PFE) phantom stock units an open-market stock purchase?

No, the phantom stock units are a compensation award, not an open-market stock purchase. They represent deferred director fees, including dividend equivalents, that will be paid in cash or common stock at Quincey’s election after he leaves the Board.

How many Pfizer (PFE) phantom stock units did James Quincey hold after the grant?

After the March 27, 2026 grant, James Quincey held 77,317.538 Phantom Stock Units. This total reflects the newly awarded 1,433.062 units added to his prior deferred balance, all tied economically to Pfizer common stock performance over time.

What does each Pfizer (PFE) Phantom Stock Unit represent for James Quincey?

Each Phantom Stock Unit represents the economic value of one Pfizer common share. These units accumulate dividend equivalents and will be settled in either cash or common stock, based on Quincey’s choice, following his retirement from Pfizer’s Board of Directors.

When will James Quincey receive value from his Pfizer (PFE) phantom stock units?

He will receive value after retiring from Pfizer’s Board of Directors. At that time, his accumulated Phantom Stock Units, including dividend equivalents, will be settled in either cash or common stock, depending on the election he makes under the deferred compensation arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 08:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Quincey James

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	03/27/2026		A		1,433.062		(2)	(2)	Common Stock	1,433.062	$27.04	77,317.538	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for James Quincey	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)